Black Patients with Cancer and COVID-19 More Likely to Have Treatment Disruptions Than White Patients

ABSTRACT

The article discusses results of a study conducted by of the American Society of Clinical Oncology (ASCO) on COVID-19 in Oncology Registry that were presented during the 2022 ASCO meeting. Topics discussed include that in America African-American patients with cancer and COVID-19 were more likely to have delays or disruptions in cancer treatment during the pandemic, discussed reasons by Dr. Jessica Islam for delay in treatment and also discussed second analysis on rural versus urban patients.